Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RGEN Repligen > Detailed Quotes

RGEN Repligen

188.330
+7.370+4.07%
Trading Session 09/28 15:05 ET
High
189.480
Open
184.520
Turnover
56.14M
Low
180.980
Pre Close
180.960
Volume
300.46K
Market Cap
10.45B
P/E(TTM)
68.24
52wk High
306.980
Shares
55.49M
P/E(Static)
84.08
52wk Low
137.210
Float Cap
9.63B
Bid/Ask %
0.00%
Historical High
327.320
Shs Float
51.14M
Volume Ratio
0.57
Historical Low
0.688
Dividend TTM
--
Div Yield TTM
--
P/B
5.79
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.59%
Amplitude
4.70%
Avg Price
186.845
Lot Size
1
Float Cap
9.63B
Bid/Ask %
0.00%
Historical High
327.320
Shs Float
51.14M
Volume Ratio
0.57
Historical Low
0.688
Dividend TTM
--
P/B
5.79
Dividend LFY
--
Turnover Ratio
0.59%
Amplitude
4.70%
Avg Price
186.845
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration, Process Analytics, and Proteins. The Chromatography product includes a range of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The Process Analytics products complement and support filtration, chromatography and proteins in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins product franchise is represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
CEO: Mr. Tony J. Hunt
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...